Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Biological therapy for inflammatory bowel disease in children
Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Na, S.Y. | - |
| dc.contributor.author | Shim, J.O. | - |
| dc.date.accessioned | 2021-09-07T04:26:14Z | - |
| dc.date.available | 2021-09-07T04:26:14Z | - |
| dc.date.created | 2021-06-17 | - |
| dc.date.issued | 2012 | - |
| dc.identifier.issn | 2234-8646 | - |
| dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/110745 | - |
| dc.description.abstract | The pathogenesis of inflammatory bowel diseases is not very well understood; it is currently thought to be caused by the interaction between genetic factors, environmental factors, intestinal microbes, and immune factors. Biological agents such as anti-tumor necrosis factor (anti-TNF) are widely being used as therapeutic agents. Infliximab, a chimeric monoclonal IgG1 antibody against tumor necrosis factor, has been demonstrated to have an effect in the induction and maintenance of remission in Crohn's disease in children. The effects of biological agents, typified by anti-TNFs, in inflammatory bowel disease in children; the recent concern on the administration of biological agents in combination with immunomodulators; and 'Top-down' therapy are some of the topics covered in this review. © 2014 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition. | - |
| dc.language | English | - |
| dc.language.iso | en | - |
| dc.publisher | Korean Society of Pediartic Gastroenterology, Hepatology and Nutrition | - |
| dc.title | Biological therapy for inflammatory bowel disease in children | - |
| dc.type | Article | - |
| dc.contributor.affiliatedAuthor | Shim, J.O. | - |
| dc.identifier.doi | 10.5223/pghn.2012.15.1.13 | - |
| dc.identifier.scopusid | 2-s2.0-84951969424 | - |
| dc.identifier.bibliographicCitation | Pediatric Gastroenterology, Hepatology and Nutrition, v.15, no.1, pp.13 - 18 | - |
| dc.relation.isPartOf | Pediatric Gastroenterology, Hepatology and Nutrition | - |
| dc.citation.title | Pediatric Gastroenterology, Hepatology and Nutrition | - |
| dc.citation.volume | 15 | - |
| dc.citation.number | 1 | - |
| dc.citation.startPage | 13 | - |
| dc.citation.endPage | 18 | - |
| dc.type.rims | ART | - |
| dc.type.docType | Review | - |
| dc.identifier.kciid | ART001648676 | - |
| dc.description.journalClass | 1 | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.description.journalRegisteredClass | kci | - |
| dc.subject.keywordAuthor | Children | - |
| dc.subject.keywordAuthor | Inflammatory bowel disease | - |
| dc.subject.keywordAuthor | Infliximab | - |
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Medical Science > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.